Keywords: آنتیبادی بخصوصی; Antibody aggregate; Aggregate removal; Hydrophobic interaction chromatography (HIC); Hydroxyapatite (HA); Mixed-mode resin; Polyethylene glycol (PEG); mAb; monoclonal antibody; bsAb; bispecific antibody; scFv; single-chain variable fragment; CHO; Chinese
مقالات ISI آنتیبادی بخصوصی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتیبادی بخصوصی; 2D-LC; Two Dimensional Liquid Chromatography; ADC; Antibody Drug Conjugate; AEX; Anion Exchange Chromatography; BEH; Bridged Ethylene Hybrid (hybrid silica); BSA; Bovine Serum Albumin; BsAb; Bispecific Antibody; CQA; Critical Quality Attribute; EMA; Europ
Keywords: آنتیبادی بخصوصی; Bleeding; Hemarthrosis; Factor concentrate; Factor VIII; Factor IX; Inhibitors; Gene therapy; Bispecific antibody;
Keywords: آنتیبادی بخصوصی; Dual specific antibody; Bispecific antibody; Bioassay; Cell proliferation; Signaling pathways; Binding assay;
Keywords: آنتیبادی بخصوصی; bsAb; bispecific antibody; CAR; chimeric antigen receptor; CDN; cyclic dinucleotides; CTL; cytotoxic T lymphocyte; CTLA-4; cytotoxic T-lymphocyte-associated protein 4; GM-CSF; granulocyte-monocyte colony stimulating factor; IR; irradiation; PD-1; Programm
Keywords: آنتیبادی بخصوصی; Antibody; Bispecific antibody; Common light chain; Common heavy chain; Heavy chain heterodimerization; Ensuring cognate light chain pairing; Common chain bispecific antibodies in clinical development;
Keywords: آنتیبادی بخصوصی; ScFv; Catalytic antibody; Expression vector; Mammalian expression; Bacterial expression; AP; alkaline phosphatase; BHQ; black hole quencher; BsAb; bispecific antibody; CD; circular dichroism; DTT; dithiothreitol; ELISA; enzyme-linked immunosorbent assay;
Keywords: آنتیبادی بخصوصی; Chimeric antigen receptor; Bispecific antibody; Hepatocellular carcinoma; Treatment;
Keywords: آنتیبادی بخصوصی; Monoclonal antibody; Bispecific antibody; Controlled Fab-arm exchange; Protein culture supernatant; Affinity purification; Protein A; Ab; Antibody; mAb; Monoclonal antibody; bsAb; Bispecific antibody; bsAb Pur; Bispecific antibody generated from purified
Keywords: آنتیبادی بخصوصی; Native mass spectrometry; Ion mobility mass spectrometry; Monoclonal antibody; Antibody-drug-conjugate; Bispecific antibody; Antibody/antigen complex;
Keywords: آنتیبادی بخصوصی; Pegylated Liposomes; Radioimmunotherapy; Bispecific Antibody; Pretargeting; Biacore;
Keywords: آنتیبادی بخصوصی; Bispecific antibody; Rheumatoid arthritis (RA); IL-1β; IL-17A;
Keywords: آنتیبادی بخصوصی; HER2; human epidermal growth factor receptor 2; HER3; human epidermal growth factor receptor 3; HRG; heregulin; IGF-1R; insulin-like growth factor-1 receptor; IGF-1; insulin-like growth factor-1; pAKT; phosphorylated AKT; dsIgG; dual-specific IgG; Immunog
Keywords: آنتیبادی بخصوصی; ADCC; antibody dependent cellular cytotoxicity; ADPh; antibody dependent phagocytosis; BsAb; bispecific antibody; CDC; complement dependent cytotoxicity; CEA; carcinoembryonic antigen; CR3; complement receptor 3; CTL; cytotoxic T-lymphocyte; DC; dendritic
Keywords: آنتیبادی بخصوصی; ADA; anti-drug antibody; ABT; antigen binding test; GSH; reduced glutathione; Natalizumab; Certolizumab; Anti-drug antibody (ADA); Bispecific antibody; Drug interference;
Immunotherapy in aggressive B-cell lymphomas
Keywords: آنتیبادی بخصوصی; B-cell lymphoma; Immunotherapy; Checkpoint blockade; Bispecific antibody;
Bispecific antibody based therapeutics: Strengths and challenges
Keywords: آنتیبادی بخصوصی; Bispecific antibody; Immunotherapy; Activated T cells;
The factor VIII heavy chain improves emicizumab-tenase assembly to enhance the factor VIII-mimicking cofactor activity
Keywords: آنتیبادی بخصوصی; Intrinsic tenase; FIXa; FX; FVIII; Bispecific antibody;
Visualisation of intracellular production bottlenecks in suspension-adapted CHO cells producing complex biopharmaceuticals using fluorescence microscopy
Keywords: آنتیبادی بخصوصی; bsAb; bispecific antibody; CHO; chinese hamster ovary; ER; endoplasmic reticulum; IgG; Immunoglobulin G; DTE; difficult-to-express; DHFR; dihydrofolate reductase; MTX; Methotrexate; VCD; viable cell density; qRT-PCR; quantitative real-time polymerase chai
Cord blood-derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19+ tumors
Keywords: آنتیبادی بخصوصی; adoptive therapy; bispecific antibody; cord blood; cytokine-induced killer; T lymphocytes;
The Use of a GroEL-BLI Biosensor to Rapidly Assess Preaggregate Populations for Antibody Solutions Exhibiting Different Stability Profiles
Keywords: آنتیبادی بخصوصی; biolayer interferometry; GroEL; monoclonal antibody; bispecific antibody; protein aggregation; stability; formulation;
Bispecific antibodies for cancer therapy: A review
Keywords: آنتیبادی بخصوصی; ADCC; antibody-dependent cell-mediated cytotoxicity; AE; adverse events; ALL; acute lymphoblastic leukemia; ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; B-ALL; B-cell acute lymphoblastic leukemia; BiTES; Bi-sp
Chemically generated IgG2 bispecific antibodies through disulfide bridging
Keywords: آنتیبادی بخصوصی; Bispecific antibody; Bioconjugation; Disulfide bridging; Click chemistry; IgG2;
PSMA-targeted bispecific Fab conjugates that engage T cells
Keywords: آنتیبادی بخصوصی; Bispecific antibody; Fab; Bioconjugation; Disulfide bridging; Click chemistry;
SPR-based assays enable the full functional analysis of bispecific molecules
Keywords: آنتیبادی بخصوصی; Ang-2; angiopoietin-2; RU; resonance units; SPR; surface plasmon resonance; VEGFA-121; vascular endothelial growth factor A; Surface plasmon resonance; Activity assessment; Bispecific antibody; Bridging assay; Dual binding assay;
Modification of cytokine-induced killer cells with folate receptor alpha (FRα)-specific chimeric antigen receptors enhances their antitumor immunity toward FRα-positive ovarian cancers
Keywords: آنتیبادی بخصوصی; ACT; adoptive cellular immunotherapy; AICD; activation induced cell death; ALL; acute lymphocytic leukemia; AML; acute myeloid leukemia; BsAb; bispecific antibody; CA125; cancer antigen-125; CARs; chimeric antigen receptors; CBMCs; cord blood mononuclear
A bispecific anti-ErbB2 antibody potently induces ErbB2 internalization and suppresses ErbB2-overexpressing tumor growth
Keywords: آنتیبادی بخصوصی; ErbB2; Monoclonal antibody; Down-regulation; Bispecific antibody; Gastric cancer;
In vitro selection of bispecific diabody fragments using covalent bicistronic DNA display
Keywords: آنتیبادی بخصوصی; Bispecific antibody; Cell-free protein synthesis; Display technology; Disulfide stabilization; PURE system; bsAb; bispecific antibody; scFv; single-chain Fv; taFv; tandem scFv; dsDb; disulfide-stabilized diabody; CDR; complementarity-determining region; F
Development, validation, and application of ELISA for detection of anti-HD105 antibodies in pre-clinical safety evaluation using monkeys
Keywords: آنتیبادی بخصوصی; Immunogenicity; Anti-drug antibody; Therapeutic proteins; Preclinical study; Validation; Bispecific antibody;
Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitro
Keywords: آنتیبادی بخصوصی; bispecific antibody; CD3; EpCAM; T lymphocyte; uterine serous cancer;
The bispecific antibody aimed at the vicious circle of IL-1β and IL-17A, is beneficial for the collagen-induced rheumatoid arthritis of mice through NF-κB signaling pathway
Keywords: آنتیبادی بخصوصی; Bispecific antibody; Rheumatoid arthritis (RA); IL-1β; IL-17A; NF-κB;
Tetravalent anti-CD20/CD3 bispecific antibody for the treatment of B cell lymphoma
Keywords: آنتیبادی بخصوصی; Bispecific antibody; CD20; Bispecific T-cell engager; Anti-CD3;
Generation and characterization of a bispecific diabody targeting both EPH receptor A10 and CD3
Keywords: آنتیبادی بخصوصی; Bispecific antibody; Diabody; EPHA10; CD3; Redirected T cell response;
Crystal structures of immunoglobulin Fc heterodimers reveal the molecular basis for heterodimer formation
Keywords: آنتیبادی بخصوصی; Immunoglobulin Fc heterodimer; CH3 domain interface; Asymmetric disulfide bonds; Thermal stability; Bispecific antibody; Fc engineeringmAb, monoclonal antibody; IgG, immunoglobulin G; Fc, fragment crystallizable; DSC, differential scanning calorimetry; RM
Improved gene amplification by cell-cycle engineering combined with the Cre-loxP system in Chinese hamster ovary cells
Keywords: آنتیبادی بخصوصی; Chinese hamster ovary cells; Gene amplification; Bispecific antibody; Cre-loxP system; Cell cycle
ReviewLife & Medical SciencesSynthetic immunity to break down the bottleneck of cancer immunotherapy
Keywords: آنتیبادی بخصوصی; Cancer immunotherapy; Synthetic immunity; Non-viral vector; Engineered antibody; Bispecific antibody; Retargeting T cell;
ReviewAlternative molecular formats and therapeutic applications for bispecific antibodies
Keywords: آنتیبادی بخصوصی; ADCC; antibody-dependent cellular cytotoxicity; ADCP; antibody-dependent cellular phagocytosis; ALL; acute lymphoblastic leukemia; AMD; age-related macular degeneration; AML; acute myeloid leukemia; BsAb; bispecific antibody; BsIgG; bispecific IgG; CDC; c
Comprehensive Analysis of the Therapeutic IgG4 Antibody Pembrolizumab: Hinge Modification Blocks Half Molecule Exchange In Vitro and In Vivo
Keywords: آنتیبادی بخصوصی; half molecule (Fab arm) exchange analysis; IgG4; bispecific antibody; pembrolizumab; cancer immunotherapy; analytical biochemistry; bioanalysis; glycoprotein; immunology; biotechnology;
Sustained Brown Fat Stimulation and Insulin Sensitization by a Humanized Bispecific Antibody Agonist for Fibroblast Growth Factor Receptor 1/βKlotho Complex
Keywords: آنتیبادی بخصوصی; Brown adipose tissue; Therapeutic antibody; Thermogenesis; Adipose tissue browning; Humanized antibody; Adiponectin; FGF21; FGF19; FGFR1; betaKlotho; UCP1; Bispecific antibody; Insulin resistance; Obesity; Type 2 diabetes; Hepatosteatosis; NASH
Heterosandwich immunoswab assay for dengue virus Ns1 antigen detection
Keywords: آنتیبادی بخصوصی; Dengue; Bispecific antibody; NS1 protein; Immunoswab
The past and future of CD33 as therapeutic target in acute myeloid leukemia
Keywords: آنتیبادی بخصوصی; Acute myeloid leukemia; Antibody; Antibody-drug conjugate; Bispecific antibody; BiTE; CD33; Chimeric antigen receptor; Gemtuzumab ozogamicin; Immunotherapy; Radioimmunoconjugate
One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles
Keywords: آنتیبادی بخصوصی; Bispecific antibody; Methoxy poly(ethylene glycol); PEGylated nanoparticle; Targeted therapy; Cancer imaging
A novel bispecific antibody targeting tumor necrosis factor α and ED-B fibronectin effectively inhibits the progression of established collagen-induce arthritis
Keywords: آنتیبادی بخصوصی; RA; rheumatoid arthritis; CIA; collagen-induced arthritis; HSA; human serum albumin; HRP; horseradish peroxidase; TNF; tumor necrosis factor; TNF-scFv; anti-TNF-α scFv; CD3-scFv; anti-CD3 scFv; IMAC; immobilized-metal affinity chromatography; MTT; 3-(4,5
A novel pancreatic β-cell targeting bispecific-antibody (BsAb) can prevent the development of Type 1 diabetes in NOD mice
Keywords: آنتیبادی بخصوصی; APC; antigen presenting cells; BsAb; bispecific antibody; mAb; monoclonal antibody; CTLA-4; cytotoxic T-lymphocyte antigen-4; GLUT2; glucose transporter 2; Treg; regulatory T-cells; DCs; dendritic cells; BMDCs; bone marrow derived DCs; T1D; type-1 diabete
Protein engineering and the use of molecular modeling and simulation: The case of heterodimeric Fc engineering
Keywords: آنتیبادی بخصوصی; RMSD; root mean squared deviation; RMSF; root mean squared fluctuation; RDF; radial distribution function; SASA; solvent exposed surface area; CCSD; close contact surface density (ÎÏtot); KBP; knowledge based potential; LJ; Lennard-Jones contributions;
Development of a highly-efficient CHO cell line generation system with engineered SV40E promoter
Keywords: آنتیبادی بخصوصی; Chinese hamster ovary (CHO) cell; Glutamine synthetase (GS); SV40 E promoter; Mammalian cell line development; Bispecific antibody;
CD20-Targeted T Cells after Stem Cell Transplantation for High Risk and Refractory Non-Hodgkin's Lymphoma
Keywords: آنتیبادی بخصوصی; Non-Hodgkin lymphoma; Activated T cells; Bispecific antibody; Autologous stem cell transplantation
Tackling the increasing complexity of therapeutic monoclonal antibodies with mass spectrometry
Keywords: آنتیبادی بخصوصی; Analytical method; Antibody (Ab); Antibody-drug conjugate (ADC); Biopharmaceutical; Biosimilar; Bispecific antibody; Glycosylation; Mass spectrometry; Native mass spectrometry; Sequence variant
A bispecific antibody against IL-1β and IL-17A is beneficial for experimental rheumatoid arthritis
Keywords: آنتیبادی بخصوصی; IL-1β; IL-17A; Bispecific antibody; Rheumatoid arthritis (RA); Antibody;
Intrahepatically transplanted human cord blood cells reduce SW480 tumor growth in the presence of bispecific EpCAM/CD3 antibody
Keywords: آنتیبادی بخصوصی; bispecific antibody; intrahepatic transplantation; mononuclear cord blood cells; newborn NOD/SCID mice; SW480 tumor growth